An Indian-American scientist has received the prestigious Springer Theses Award for his outstanding research on developing transgenic mice to study a critical tumor-suppressor.

Arnab De, who has also developed peptide-based prodrugs as therapeutics for diabetes, was nominated by New York’s Columbia University for his PhD thesis.

De, who has also received the Young Investigator Award at the American Peptide Symposium, was awarded for developing transgenic mice to study a critical tumor-suppressor A20.

The Springer Theses Award is awarded by Springer, a leading global publisher of renowned scientific journals and books, to recognise outstanding PhD research.

Internationally top-ranked research institutes select their best thesis annually for publication in the book series: “Springer Theses: Recognising Outstanding PhD research”.

The winners also get a cash prize of 500 euros (USD 555).  The research work was highlighted by the European Molecular Biology Organization (EMBO) Reports.  Only research considered to be of fundamental relevance to a general readership is chosen to be highlighted by EMBO.

Source: India Today